Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor | Zendy

Jens Gläser | Zendy; Ada Sedova | Zendy; Stephanie Galanie | Zendy; Daniel W. Kneller | Zendy; Russell B. Davidson | Zendy; Elvis Maradzike | Zendy; Sara Del Galdo | Zendy; Audrey Labbé | Zendy; Darren J. Hsu | Zendy; Rupesh Agarwal | Zendy; Dmytro Bykov | Zendy; Arnold Tharrington | Zendy; Jerry M. Parks | Zendy; Dayle M. A. Smith | Zendy; Isabella Daidone | Zendy; Leighton Coates | Zendy; Andrey Kovalevsky | Zendy; Jeremy C. Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor

Author(s) -

Jens Gläser,

Ada Sedova,

Stephanie Galanie,

Daniel W. Kneller,

Russell B. Davidson,

Elvis Maradzike,

Sara Del Galdo,

Audrey Labbé,

Darren J. Hsu,

Rupesh Agarwal,

Dmytro Bykov,

Arnold Tharrington,

Jerry M. Parks,

Dayle M. A. Smith,

Isabella Daidone,

Leighton Coates,

Andrey Kovalevsky,

Jeremy C. Smith

Publication year - 2022

Publication title -

acs pharmacology and translational science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.271

H-Index - 10

ISSN - 2575-9108

DOI - 10.1021/acsptsci.2c00026

Subject(s) - pharmacophore , chemistry , isoquinoline , drug discovery , protease , stereochemistry , covalent bond , protease inhibitor (pharmacology) , ligand efficiency , combinatorial chemistry , non covalent interactions , protein data bank (rcsb pdb) , cheminformatics , enzyme , computational biology , biochemistry , ligand (biochemistry) , molecule , computational chemistry , hydrogen bond , biology , virus , virology , organic chemistry , receptor , antiretroviral therapy , viral load

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research